ST. LOUIS, Jan. 11, 2011 /PRNewswire/ — Stereotaxis, Inc.
(Nasdaq:
STXS) announces the first successful cardiac ablation procedure
with the Vdrive™ robotic navigation system as the company
received CE Mark for this latest innovation.
In the first procedure with the Vdrive system, Tamas
Szili-Torok, MD, Ph.D., from the Department of Clinical
Electrophysiology at the Erasmus Medical Center in The Netherlands,
successfully treated atrial fibrillation in a patient with known
difficult heart anatomy. Dr. Szili-Torok was able to complete
the entire case without having to manually adjust the circular
mapping catheter.
“This first use of the Vdrive robotic navigation system exceeded
my expectations,” said Dr. Szili-Torok. “The robotic navigation of
the circular mapping catheter was intuitive and allowed me to make
multiple small precise adjustments from the control room to
efficiently treat my patient’s atrial fibrillation.”
Stereotaxis’ Vdrive system is a robotic navigation technology
that compliments the Stereotaxis Remote Magnetic Navigation System.
Designed to manipulate accessory devices such as variable loop
catheters, steerable sheaths, and ultrasound catheters, Vdrive
combines magnetic navigation with the Odyssey information
management system to bring precise control during catheter-based
electrophysiology procedures.
“The Vdrive system is an extension of the magnetic navigation
platform capabilities,” said Michael P. Kaminski, President and
Chief Executive Officer of Stereotaxis, Inc. “Along with
QuickCAS™ Catheter Advancement System, the Vdrive system
represents an additional component to our expanding disposable
product portfolio designed to bring compelling efficiency to the
Electrophysiology lab.”
The Vdrive system is commercially available in the European
Union. The Vdrive system is not currently availab
‘/>”/>
